Colorectal cancer is the second leading cause of cancer-related deaths in the United States. It’s also one of the most preventable cancers we know of — but only if you choose the right screening tool, at the right time, for your individual risk level. This guide gives you everything you need to make that decision with confidence.
We’re going to cover every major screening option currently available, what the actual clinical data shows about each one’s accuracy, what happens when a stool test comes back positive, and — most importantly — which test is right for you specifically.
Why Colon Cancer Screening Starts at Age 45
Before we compare tests, let’s address the number one reason people skip screening altogether: they think they’re too young or feel too healthy to need it.
Both the American Cancer Society (ACS) and the U.S. Preventive Services Task Force (USPSTF) now recommend colorectal cancer screening beginning at age 45 for average-risk adults. That’s a significant change from the previous age-50 recommendation, driven by alarming data showing colorectal cancer rates in adults under 50 rising by approximately 2% per year since the mid-1990s.
The USPSTF and ACS both recommend screening for ages 45–75, recently lowered from a starting age of 50. Most commonly-used modalities include annual FIT testing, FIT+DNA testing every three years, and colonoscopy every ten years, with shorter repeat intervals if polyps are found.
Your Colorectal Cancer Screening Options — A Complete Overview
There are more ways to screen for colorectal cancer today than ever before. They fall into two broad categories: stool-based tests (done at home, non-invasive) and visual exams (done by a gastroenterologist, allow direct inspection and removal of polyps).
Stool-based tests:
- Fecal Immunochemical Test (FIT) — annually
- Multi-target stool DNA test (Cologuard / Cologuard Plus) — every 3 years
- High-sensitivity guaiac fecal occult blood test (gFOBT) — annually (largely replaced by FIT)
- Multi-target stool RNA test (ColoSense) — newer, not yet widely covered
Visual exams:
- Colonoscopy — every 10 years (if normal)
- CT colonography (virtual colonoscopy) — every 5 years
- Flexible sigmoidoscopy — every 5 years (examines only the lower colon)
Blood-based tests (newer):
- Shield, Simple Screen — available but not yet preferred by ACS or rated A/B by USPSTF; should only be used when patients refuse both stool tests and visual exams.
Colonoscopy: The Gold Standard — and Why It Earns That Title
A colonoscopy is the only screening test that is simultaneously diagnostic and therapeutic. Every other screening tool on this list can only detect a potential problem — a colonoscopy can find it, assess it, and remove it, all in the same 30–45 minute procedure.
What colonoscopy can detect:
- Colorectal cancer at all stages, including very early
- Adenomatous polyps (precancerous) of virtually any size — including the small flat lesions that stool tests miss entirely
- Sessile serrated lesions — the “sneaky” polyps that flat tests frequently miss
- Diverticular disease, IBD, and other structural abnormalities of the colon
Colonoscopy interval: Every 10 years if no polyps are found. If adenomas are found and removed, the interval shortens to 3–7 years depending on size and number. If advanced adenomas or high-risk findings are present, surveillance may be recommended every 1–3 years.
Cologuard (Stool DNA Test): What It Is and What It Can — and Cannot — Do
Cologuard is the brand name for the multi-target stool DNA test (mt-sDNA). You’ve probably seen it advertised. The appeal is obvious: it’s done entirely at home, requires no prep, no sedation, no time off work, and no doctor’s office visit. A kit is mailed to your home, you collect a stool sample, and you mail it to a laboratory. Results come within two weeks.
Cologuard analyzes your stool for two things: abnormal DNA shed from polyps or tumors, and hemoglobin (blood in the stool). Colorectal cancers and precancerous polyps shed DNA into the stool as cells turn over — Cologuard’s molecular panel is designed to detect those specific DNA changes.
- For detecting colorectal cancer already present: Cologuard is quite good — 92% sensitivity means it catches roughly 9 out of 10 existing cancers. That’s meaningful.
- For detecting large precancerous polyps before they become cancer: 42% sensitivity means it misses more than half. This is the critical limitation that patients rarely hear about.
The difference between these two numbers is the difference between detection and prevention. Catching a cancer that’s already formed is valuable — but removing a polyp before it ever becomes cancer is fundamentally different, and that’s where colonoscopy’s superiority is most pronounced.
Cologuard interval: Every 3 years (FDA-approved interval). A positive result requires a colonoscopy, regardless of the interval.
Who Cologuard is appropriate for:
- Average-risk adults aged 45–75 who are unwilling or unable to undergo colonoscopy
- Patients with no personal or family history of colorectal cancer, IBD, or hereditary syndromes
- Those who understand its limitations and are committed to follow-up colonoscopy if the result is positive
FIT Test: The Simple Annual Option Most People Overlook
The fecal immunochemical test (FIT) doesn’t get the advertising budget that Cologuard does, but it’s one of the most cost-effective, widely available colorectal cancer screening tools we have — and the American Cancer Society considers it a preferred option alongside colonoscopy and Cologuard.
FIT uses antibodies specific to human hemoglobin to detect blood in the stool — blood that can signal a polyp or tumor bleeding into the colon. It’s simpler than Cologuard (no DNA analysis), less expensive, and more widely covered by insurance. It requires only one small stool sample on a special collection card, mailed to a lab.
Compared to Cologuard’s 92% cancer sensitivity, FIT’s 67% looks lower. But here’s the nuance: FIT is done annually. Cologuard is done every three years. Annual testing with a somewhat less sensitive test can be clinically equivalent to less frequent testing with a more sensitive test — because you’re catching things earlier in the interval rather than waiting three years.
FIT is most appropriate for:
- Average-risk adults who can commit to annual testing every single year
- Patients who want the most accessible, lowest-cost option
- Those who understand that a positive FIT always requires follow-up colonoscopy
Head-to-Head Comparison: Colonoscopy vs. Cologuard vs. FIT
| Colonoscopy | Cologuard / Cologuard Plus | FIT | |
|---|---|---|---|
| Cancer detection (sensitivity) | ~95% | 92–93.9% | 67–74% |
| Large polyp detection | ~95% | 42% | 23% |
| Specificity (avoids false positives) | Gold standard | 87–91% | 95–96% |
| Removes polyps during procedure | ✅ Yes — immediately | ❌ No | ❌ No |
| Requires bowel prep | Yes | No | No |
| Requires sedation | Yes | No | No |
| Done at home | No | Yes | Yes |
| Frequency | Every 10 years | Every 3 years | Every year |
| If positive, requires colonoscopy | N/A | Yes | Yes |
| Insurance coverage | Widely covered | Widely covered | Widely covered |
| Best for | All risk levels; highest accuracy | Average-risk; colonoscopy-averse | Average-risk; committed to annual testing |
What Happens if Your Cologuard or FIT Test Is Positive?
This is the question patients most frequently fail to ask before choosing a stool test — and the answer changes the calculus significantly.
A positive result on any stool test is not a diagnosis. It means the test detected something worth investigating — abnormal DNA, blood, or both. The only way to know what’s actually there is a colonoscopy.
If you receive a positive result, it means the test detected DNA and/or blood in the stool, either due to polyps or cancer. After a positive Cologuard test, a colonoscopy is required for a definitive answer.
Here’s what this means practically:
- If your Cologuard is positive: You’ll need a diagnostic colonoscopy. This is now coded differently than a screening colonoscopy for insurance purposes in some plans — meaning your cost-sharing may be different. Check your insurance coverage before assuming the follow-up colonoscopy is fully covered as a screening procedure.
- If your FIT is positive: Same situation — diagnostic colonoscopy needed to identify and treat the source of bleeding.
- If your stool test is negative: You’re not done forever. You repeat the test on schedule (annually for FIT, every 3 years for Cologuard). A negative result provides reassurance for that cycle only.
Non-Invasive Colon Cancer Screening: Who It’s Really Right For
Stool-based testing and CT colonography are genuinely valuable screening tools — for the right patients.
Non-invasive screening makes sense if:
- You are average-risk (no personal history of polyps, no significant family history, no IBD or hereditary syndrome)
- You have a medical condition that makes colonoscopy prep or sedation risky
Non-invasive screening is NOT appropriate if:
- You have a personal history of colorectal polyps (especially adenomas)
- You have Crohn’s disease or ulcerative colitis
- You’ve had a prior positive stool test that wasn’t followed up with a colonoscopy
Does Insurance Cover Colon Cancer Screening?
Under the Affordable Care Act, preventive colorectal cancer screening is covered at 100% with no cost-sharing (no copay, no deductible) for average-risk adults aged 45–75 at in-network providers. This applies to colonoscopy, FIT, and Cologuard.
The diagnostic colonoscopy after a positive stool test: In some insurance plans, a colonoscopy performed because of a positive stool test is coded as a diagnostic procedure rather than a preventive screening. This can result in cost-sharing. Some states have laws prohibiting this, and federal rules have been updated to close this gap for many plans — but coverage varies. Always check with your insurance before assuming the follow-up colonoscopy is free.
High-risk patients: If you’re screened more frequently due to family history or prior polyps, some of those additional colonoscopies may be coded as diagnostic or surveillance rather than preventive — which can affect your cost-sharing. Discuss this with both your gastroenterologist’s billing team and your insurance plan.
Get Screened in Conyers, GA — Don’t Put It Off Another Year
At Colon & Digestive Health Specialists, Dr. Karim Shakoor, M.D. and our team have been helping patients across Conyers, Rockdale County, Newton County, and Henry County navigate exactly this decision. We don’t push one test over another based on convenience — we help you choose the right screening strategy for your individual risk, your medical history, and your real-world ability to follow through.
If you’re 45 or older and haven’t been screened — or if you’re overdue for a follow-up colonoscopy — now is the time.
If you’ve had a positive stool test and haven’t followed up with a colonoscopy, please don’t wait. A positive result that isn’t followed up provides zero protection.